Member Info for researcher1

in some ways I'm pleased the news is on hold - any rise would have been sold into by distressed sellers today, and we'd also drift back on the FDA wait. Much better to announce the submission post-Corona (FDA should have plenty of slots then ...), along with other research progress.

Grail is not a competitor for Angle - totally separate screening technology. AGL is way ahead of the competition, despite the (hopefully short) delay.

Company IR say dubbing progressing at considerable pace recently, so profits must be surging!

that's a really annoying reason for delay - presumably the blood had to be taken close to submission? Once there is the antibody test, surely this can go ahead safely, so perhaps not as long a wait. Let's hope they progress other research meanwhile...and at least they have plenty of cash to hand, unlike many companies.

I had an email reply from AN on Wednesday to exactly that question. Answer: there can be no certainty as to when etc etc....
but also: that they are still obliged to reply as per the schedule (within 180 days)

same here - I would expect Angle to hit its deadlines having worked so hard to get in this position. It is unaffected by C19 as far as I understand, and is already selling more and more P units at 50K a pop. Low SP is purely stressed selling....

crazy cheap for company with strong future. I'm in.

really pleased with that update. Hang onto these over the summer and they will come very good....

are we talking of £2 minimum after this?

AN has shares coming out of his eyeballs and a huge incentive package, so no point in hoping for that. Instead let's urge him to get the FDA submission in on time (11 days). That should give the SP a superboost, especially as C19 has almost zero effect on Angle. I also read in NS that two more institutes were testing P. so looks like research sales are growing. With FDA and end of C19 this is going into orbit.

Angle is fully funded through to 2021, and as I understand, not impacted by Covid in terms of working practices, although the FDA may try to extend the 180 day limit (if a vaccine comes out etc) - so nothing has changed apart from investors being a bit short of a penny or two....

Angle is fully funded through to 2021, and as I understand, not impacted by Covid in terms of working practices, although the FDA may try to extend the 180 day limit (if a vaccine comes out etc) - so nothing has changed apart from investors being a bit short of a penny or two....

in these circumstances there really is no telling what the FDA might do - I'm sure exceptions to standard procedure can be made... hence today's drop I assume...

Money simply pouring out of AIM, as you'd expect. Wish I'd acted a bit sooner, but isn't that always the case?

I'm looking at it too. Dividend is about £1 per share, so incredible at this price (and 50p of that is coming soon) HOWEVER they do have a lot of debt, so the market is thinking: can they survive the order lull caused by CV especially in China?

hi, could someone remind me when and how much the dividend on this share is please? looks like a great price to get in, but who dares to at the moment??

makes a lot of sense to me Tina, but my calculations against current sales against MCAP suggest this should be around 140 - 150, can you reveal your workings to get 120? thanks

yeah it's pretty painful to look at just now - but Zoo's activities are some of the least likely to be impacted - distressed selling rules for now. People will need movies! Let's hope the update is good...

everyone worries about dilution, forgetting that the cash sits on the black side of the ledger

I'm back in at 124 - the 100M on the balance sheet is welcome....

maybe some value now at this level - but I just can't bring myself to buy anything belonging to ME, being the incompetent clown he is. I may regret it, but I certainly now don't regret selling up at 42p (even with a £6K loss).